Revolution Medicines Inc
RVMD
Market Cap$7.1B
Close$
$2.43
93.8% downside
Current Fair Value
93.8% downsideOvervalued by 93.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.10 Billion |
|---|---|
| Enterprise Value | $6.90 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.58 |
| Beta | 1.16 |
| Outstanding Shares | 188,145,904 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -8.8 |
|---|---|
| PEG | -14.62 |
| Price to Sales | 38.95 |
| Price to Book Ratio | 3.54 |
| Enterprise Value to Revenue | 26.37 |
| Enterprise Value to EBIT | -8.15 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Revolution Medicines Inc
CEO: Mark Goldsmith